Amgen AMGN
NASDAQ AMGN
$437.23 -6.89 (-1.55%)
At close: Sep 4, 2026 · 4:00 PM EDT

Amgen (AMGN) EV to CFO (2009 - 2026)

Amgen (AMGN) posted EV to CFO of 45.42 for Q2 2026, down 44.1% on a QoQ basis from 81.25 in Q1 2026, and down 27.21% year-over-year from 62.4 in Q2 2025.

Analysis

Amgen (AMGN) EV to CFO (2009 - 2026) Analysis & Trends

Amgen has reported EV to CFO for 18 years, with the latest figure at 45.42 in Q2 2026.

  • On a quarterly basis, EV to CFO fell 27.21% year-over-year to 45.42 in Q2 2026; TTM through Jun 2026 was 14.57, a 23.0% increase from a year earlier, with the FY2025 full-year figure at 16.79, up 50.79% from the prior year.
  • EV to CFO was 45.42 for Q2 2026 at Amgen, down from 81.25 in the prior quarter.
  • The five-year high for EV to CFO was 266.29 in Q4 2023, with the low at 20.57 in Q2 2023.
  • Average EV to CFO over 5 years is 78.16, with a median of 59.54 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: EV to CFO surged 438.69% in 2023, then plunged 89.93% in 2024.
  • Over 5 years, EV to CFO stood at 49.43 in 2022, then soared by 438.69% to 266.29 in 2023, then slumped by 89.93% to 26.82 in 2024, then soared by 288.95% to 104.32 in 2025, then sank by 56.46% to 45.42 in 2026.
  • The last three EV to CFO figures came in at 45.42 (Q2 2026), 81.25 (Q1 2026), and 104.32 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.42
Mar 31, 2026 81.25
Dec 31, 2025 104.32
Sep 30, 2025 30.43
Jun 30, 2025 62.40
Mar 31, 2025 114.10
Dec 31, 2024 26.82
Sep 30, 2024 45.98
Jun 30, 2024 64.48
Mar 31, 2024 207.26
Dec 31, 2023 266.29
Sep 30, 2023 39.52
Jun 30, 2023 20.57
Mar 31, 2023 91.70
Dec 31, 2022 49.43
Sep 30, 2022 36.53
Jun 30, 2022 63.71
Mar 31, 2022 56.67
Dec 31, 2021 41.87
Sep 30, 2021 44.35